ACAD
32.78
-0.57
-1.7103%
AEMD
0.233
-0.008
-3.1250%
APRI
1.92
0.00
0.00%
ARNA
4.42
-0.06
-1.34%
ATEC
1.41
0.00
0.00%
CNAT
7.12
-0.41
-5.44%
CRXM
0.195
0.00
0.00%
CYTX
1.19
-0.01
-0.83%
DXCM
62.76
+0.78
+1.26%
GNMK
13.05
-0.25
-1.88%
HALO
14.43
+0.43
+3.07%
ILMN
186.2
-1.42
-0.76%
INNV
0.179
0.00
0.00%
INO
8.24
-0.09
-1.08%
ISCO
0.059
+0.001
+0.855%
ISIS
64.87
+0.06
+0.09%
LGND
77.42
+1.19
+1.56%
LPTN
2.4
-0.07
-2.83%
MBVX
1.86
0.00
0.00%
MEIP
1.789
+0.039
+2.229%
MNOV
3.43
-0.16
-4.46%
MRTX
28.78
-0.33
-1.13%
MSTX
0.49
-0.008
-1.5678%
NBIX
39.77
-1.76
-4.24%
NUVA
46.3
-0.1
-0.22%
ONCS
0.335
-0.015
-4.286%
ONVO
3.52
+0.15
+4.45%
OREX
7.9
+0.15
+1.94%
OTIC
34.52
-1.11
-3.12%
QDEL
27.06
-0.44
-1.60%
RCPT
166.3
+6.25
+3.91%
RGLS
17.28
+0.02
+0.12%
RMD
72.03
+0.38
+0.53%
SCIE
0.03
0.00
+17.65%
SPHS
0.558
+0.008
+1.5091%
SRNE
11.745
+0.385
+3.3900%
TROV
6.9
-0.1
-1.43%
VICL
0.935
+0.035
+3.8778%
VOLC
17.99
0.00
0.00%
ZGNX
1.384
+0.014
+1.0292%
ACAD
32.78
-0.57
-1.7103%
AEMD
0.233
-0.008
-3.1250%
APRI
1.92
0.00
0.00%
ARNA
4.42
-0.06
-1.34%
ATEC
1.41
0.00
0.00%
CNAT
7.12
-0.41
-5.44%
CRXM
0.195
0.00
0.00%
CYTX
1.19
-0.01
-0.83%
DXCM
62.76
+0.78
+1.26%
GNMK
13.05
-0.25
-1.88%
HALO
14.43
+0.43
+3.07%
ILMN
186.2
-1.42
-0.76%
INNV
0.179
0.00
0.00%
INO
8.24
-0.09
-1.08%
ISCO
0.059
+0.001
+0.855%
ISIS
64.87
+0.06
+0.09%
LGND
77.42
+1.19
+1.56%
LPTN
2.4
-0.07
-2.83%
MBVX
1.86
0.00
0.00%
MEIP
1.789
+0.039
+2.229%
MNOV
3.43
-0.16
-4.46%
MRTX
28.78
-0.33
-1.13%
MSTX
0.49
-0.008
-1.5678%
NBIX
39.77
-1.76
-4.24%
NUVA
46.3
-0.1
-0.22%
ONCS
0.335
-0.015
-4.286%
ONVO
3.52
+0.15
+4.45%
OREX
7.9
+0.15
+1.94%
OTIC
34.52
-1.11
-3.12%
QDEL
27.06
-0.44
-1.60%
RCPT
166.3
+6.25
+3.91%
RGLS
17.28
+0.02
+0.12%
RMD
72.03
+0.38
+0.53%
SCIE
0.03
0.00
+17.65%
SPHS
0.558
+0.008
+1.5091%
SRNE
11.745
+0.385
+3.3900%
TROV
6.9
-0.1
-1.43%
VICL
0.935
+0.035
+3.8778%
VOLC
17.99
0.00
0.00%
ZGNX
1.384
+0.014
+1.0292%

Headline »

March 2, 2015 – 7:18 pm

In 2011 the San Diego Biotechnology Network (SDBN) hosted an event on “virtual” drug discovery, the then burgeoning idea that successful therapies could result from very small companies that rely on the internet-driven infrastructure to …

Read the full story »

Breaking San Diego Biotech News

From Iceland to White House, Precision Medicine’s Promises & Hurdles

March 31, 2015 – 3:30 am

There is talk, and there is action. In the drive toward healthcare tailored for smaller and smaller groups of people, there was both last week, and both illustrated not just the promise of precision…

[[Click headline to continue reading.]]

Celladon Corporation Reports Fourth Quarter And Year-End 2014 Financial Results And Recent Highlights

March 30, 2015 – 5:00 pm

CUPID2 Topline Data Release on Track for Late April Conference Call March 31, 2015 at 8:30 a.m. Eastern Time SAN DIEGO, March 30, 2015 (GLOBE NEWSWIRE) — Celladon Corporation (Nasdaq:CLDN), a clinical-stage…

Althea’s New Drug Formulation Technology Gains Attention From Two More Top Pharmaceutical Companies

March 30, 2015 – 5:00 pm

SAN DIEGO, March31, 2015 /PRNewswire/ –Ajinomoto Althea, Inc. (“Althea”), a leading provider of biopharmaceutical contract development and manufacturing services, announced today that it has added two more top pharmaceutical companies to its growing l…

3D Human Skin Maps Aid Study of Relationships Between Molecules, Microbes and Environment

March 30, 2015 – 2:08 pm

Researchers at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences produced 3D maps of molecular and microbial variations across the body. These maps provide a baseline for studies of the interplay between the molecules that make up our skin, our microbiomes, our personal hygiene routines and other environmental factors. The study, published March 30 by PNAS, may help further our understanding of the skin’s role in human health and disease.


See All News>>

Newest San Diego Biotech Jobs

Scientific Program Manager – Salk Institute for Biological Studies – E627

Position Description:
Incumbent will serve as project manager for preclinical and clinical research efforts including guidance, strategy and execution. Duties include but are not limited to: leadership of project team, supervision of technicians, managing pre-clinical strategies …

Lab Operations Support Manager (San Diego, CA)

Job Description:
The Operations Support Manager is responsible for managing a San Diego, California laboratory and facility. This position will ensure processes and services are monitored for quality, cost effectiveness, and efficiency through conti […

Process Development Engineer II/III – Planet Pharma – San Diego, CA

Title: Process Development Engineer II/III Company: Biopharmaceutical Duration: Permanent Location: San Diego, CA Role: The Process Development Engineer will
From Planet Pharma – 31 Mar 2015 03:27:27 GMT
– View all San Diego jo…

Research Associate – BioPhase Solutions – San Diego, CA

Degree in Molecular Biology, Biochemistry, Microbiology, Biotechnology or related discipline. We are currently looking for a Research Associate to work for a…
From BioPhase Solutions – 31 Mar 2015 00:20:04 GMT
– View all San …


See All Jobs>>

San Diego Biotech Blog Feed

Trilink: Liquid Biopsies Are Viewed as “Liquid Gold” for Diagnostics

Invasive Needles and Scalpels Seen as Passé Noninvasive Sampling Advocates Focusing on Circulating Tumor Cells (CTCs)  New Companies are Pursuing the Liquid Biopsy “Gold Rush” Biopsy Basics As defined in Wikipedia, a biopsy is ‘a medical test commonly performed by … Continue reading →... More...

Membrane Penetration: The Super Fins!

Hello! I am going to be writing some articles for a cool new aquatic news website called The Super Fins. Check out my first piece!  Meet the Notothenioid Fish: Antarctic Icefish Uses Antifreeze in Blood to Survive... More...

Ryon Graf: STEAM day at Muirlands Middle School

29 March 2015 About a week ago I had the honor and privilege to attend Muirlands Middle School’s STEAM career day as an invited speaker. The last time I set foot on the Muirlands campus I was a student. As I walked by the front gate I had the distinct recollection of the sound of... More...

Su Lab: What the heck is NGLY1 and why is Mark2Cure targeting it in the next campaign?

NGLY1 is the gene encoding for Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) AKA N-glycanase 1. A deficiency in this enzyme can disrupt protein quality control mechanisms in the cell, which as we’ve seen in the BioGPS Gene-of-the-week on BAG6 is very important. Learn... More...